oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Hycamtin

The identified deviation concerns the active substance content. Administration of the medicine with an increased amount of topotecan may negatively affect treatment tolerability; haematological toxic effects are dose-dependent and may pose a health risk to the patient. Potential effects: haematological toxicity, complications of oncological treatment.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Hycamtin
Risk Level
High
Manufacturer
Sandoz Pharmaceuticals d.d., Verovškova ulica 57, 1000 Ljubljana, Slovenia;
Batch Number
BCUN2
EAN Code
05909990643141
Recall Date
02.10.2023
View official statement

Important Information

What You Should Know

Recommendations

Do not use Hycamtin (Topotecan) products with batch numbers BCUN2 and BCUN3; if you possess these packs, contact a pharmacist or doctor.

Actions Taken

The Chief Pharmaceutical Inspector prohibited the placement on the market throughout the country of Hycamtin (Topotecan) batches BCUN2 and BCUN3 and granted the decision immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: The identified deviation concerns the active substance content. Administration of the medicine with an increased amount of topotecan may negatively affect treatment tolerability; haematological toxic effects are dose-dependent and may pose a health risk to the patient. Potential effects: haematological toxicity, complications of oncological treatment.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: BCUN2

Related

Other Recalled Products